Finance

Lists
CSCI:TSE
COSCIENS Biopharma Inc
CA$7.45
0.00%
(0.00) 1D
Sep 15, 1:55:32 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CSCI...
Mkt. cap
7.91M
Avg. vol.
691.00
Volume
0.00
P/E ratio
0.85
52-wk high
CA$14.80
52-wk low
CA$3.30
EPS
CA$8.76
Beta
1.51
Shares outstanding
996.39K
No. of employees
28
Mkt. cap
7.91M
Avg. vol.
691.00
Volume
0.00
P/E ratio
0.85
52-wk high
CA$14.80
52-wk low
CA$3.30
EPS
CA$8.76
Beta
1.51
Shares outstanding
996.39K
No. of employees
28
News stories
From web sources and news partners
About COSCIENS Biopharma Inc
CEO-
Employees28
Founded1990
HeadquartersToronto, Ontario, Canada
SectorBiotechnology
Websitecosciensbio.com
Last report
Aug 11, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -
Revenue / Est. (USD)
3.14M / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.48M
1.77M
1.89M
3.14M
Cost of goods sold
938.00K
1.16M
1.10M
1.41M
Cost of revenue
938.00K
1.16M
1.10M
1.41M
Research and development expenses
527.00K
599.00K
176.00K
132.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.10M
2.40M
1.35M
1.18M
Operating expense
2.63M
3.00M
1.52M
1.32M
Total operating expenses
3.57M
4.15M
2.62M
2.72M
Operating income
-2.08M
-2.39M
-730.00K
422.00K
Other non operating income
522.00K
240.00K
562.00K
-680.00K
EBT including unusual items
-1.82M
-2.17M
-183.00K
-202.00K
EBT excluding unusual items
-1.58M
-2.17M
-183.00K
-202.00K
Income tax expense
-
10.00K
-
-
Effective tax rate
-
-0.46%
-
-
Other operating expenses
-
-
-
-
Net income
-1.82M
-2.18M
10.76M
-202.00K
Net profit margin
-122.66%
-123.61%
569.76%
-6.43%
Earnings per share
-
-
-
-
Interest and investment income
57.00K
37.00K
20.00K
22.00K
Interest expense
-43.00K
-32.00K
-46.00K
-51.00K
Net interest expenses
14.00K
5.00K
-26.00K
-29.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.80M
-2.36M
-389.00K
759.00K
Gain or loss from assets sale
-
-
-11.28M
29.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps